<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36214080</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>57</StartPage><EndPage>68</EndPage><MedlinePgn>57-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.15589</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Weight loss in patients with amyotrophic lateral sclerosis (ALS) is associated with faster disease progression and shorter survival. Decreased hypothalamic volume is proposed to contribute to weight loss due to loss of appetite and/or hypermetabolism. We aimed to investigate the relationship between hypothalamic volume and body mass index (BMI) in ALS and Alzheimer's disease (AD), and the associations of hypothalamic volume with weight loss, appetite, metabolism and survival in patients with ALS.</AbstractText><AbstractText Label="METHODS">We compared hypothalamic volumes from magnetic resonance imaging scans with BMI for patients with ALS (n&#xa0;=&#xa0;42), patients with AD (n&#xa0;=&#xa0;167) and non-neurodegenerative disease controls (n&#xa0;=&#xa0;527). Hypothalamic volumes from patients with ALS were correlated with measures of appetite and metabolism, and change in anthropomorphic measures and disease outcomes.</AbstractText><AbstractText Label="RESULTS">Lower hypothalamic volume was associated with lower and higher BMI in ALS (quadratic association; probability of direction&#xa0;=&#xa0;0.96). This was not observed in AD patients or controls. Hypothalamic volume was not associated with loss of appetite (p&#xa0;=&#xa0;0.58) or hypermetabolism (p&#xa0;=&#xa0;0.49). Patients with lower BMI and lower hypothalamic volume tended to lose weight (p&#xa0;=&#xa0;0.08) and fat mass (p&#xa0;=&#xa0;0.06) over the course of their disease, and presented with an increased risk of earlier death (hazard ratio [HR]&#xa0;3.16, p&#xa0;=&#xa0;0.03). Lower hypothalamic volume alone trended for greater risk of earlier death (HR&#xa0;2.61, p&#xa0;=&#xa0;0.07).</AbstractText><AbstractText Label="CONCLUSION">These observations suggest that lower hypothalamic volume in ALS contributes to positive and negative energy balance, and &#xa0;is not universally associated with loss of appetite or hypermetabolism. Critically, lower hypothalamic volume with lower BMI was associated with weight loss and earlier death.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jeryn</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6659-365X</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Thomas B</ForeName><Initials>TB</Initials><Identifier Source="ORCID">0000-0003-2490-0532</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Advanced Imaging, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Information Technology and Electrical Engineering, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holdom</LastName><ForeName>Cory J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0001-5972-6437</Identifier><AffiliationInfo><Affiliation>Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCombe</LastName><ForeName>Pamela A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-2704-8517</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UQ Centre for Clinical Research, The University of Queensland, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wesley Medical Research, The Wesley Hospital, Auchenflower, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-2820-8183</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UQ Centre for Clinical Research, The University of Queensland, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wesley Medical Research, The Wesley Hospital, Auchenflower, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fripp</LastName><ForeName>Jurgen</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9705-0079</Identifier><AffiliationInfo><Affiliation>CSIRO Health and Biosecurity, Herston, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barth</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0520-1843</Identifier><AffiliationInfo><Affiliation>Centre for Advanced Imaging, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Information Technology and Electrical Engineering, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Christine C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0003-1530-0172</Identifier><AffiliationInfo><Affiliation>ActiGraph, LLC, Pensacola, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Shyuan T</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0002-1388-2108</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wesley Medical Research, The Wesley Hospital, Auchenflower, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyn</LastName><ForeName>Frederik J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0002-4782-3608</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Saint Lucia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wesley Medical Research, The Wesley Hospital, Auchenflower, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Alzheimer's Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">hypothalamus</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">weight loss</Keyword></KeywordList><CoiStatement>The authors have declared no conflict of interest for this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36214080</ArticleId><ArticleId IdType="pmc">PMC10099625</ArticleId><ArticleId IdType="doi">10.1111/ene.15589</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14(4):248&#x2010;264. doi:10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(1):20&#x2010;24. doi:10.1002/mus.22114</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22114</ArticleId><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Limousin N, Blasco H, Corcia P, et al. Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. J Neurol Sci. 2010;297(1&#x2013;2):36&#x2010;39. doi:10.1016/j.jns.2010.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.06.028</ArticleId><ArticleId IdType="pubmed">20673675</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population&#x2010;based cohort. J Neurol Neurosurg Psychiatry. 2019;90(6):666&#x2010;673. doi:10.1136/jnnp-2018-319611</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Steyn F, Dupuis L. Hypothalamus and weight loss in amyotrophic lateral sclerosis. Handb Clin Neurol. 2021;180:327&#x2010;338. doi:10.1016/b978-0-12-820107-7.00020-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-820107-7.00020-3</ArticleId><ArticleId IdType="pubmed">34225938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides ZA, Ngo ST, Henderson RD, McCombe PA, Steyn FJ. Altered metabolic homeostasis in amyotrophic lateral sclerosis: mechanisms of energy imbalance and contribution to disease progression. Neurodegener Dis. 2016;16(5&#x2013;6):382&#x2010;397. doi:10.1159/000446502</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446502</ArticleId><ArticleId IdType="pubmed">27400276</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, Nagaoka U, Nakayama Y, et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan. Amyotroph Lateral Scler. 2012;13(4):363&#x2010;366. doi:10.3109/17482968.2012.678366</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.678366</ArticleId><ArticleId IdType="pubmed">22632442</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J&#x2010;W, Kim M, Baek S&#x2010;H, Sung JH, Yu J&#x2010;G, Kim B&#x2010;J. Body fat percentage and availability of oral food intake: prognostic factors and implications for nutrition in amyotrophic lateral sclerosis. Nutrients. 2021;13(11):3704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8622757</ArticleId><ArticleId IdType="pubmed">34835960</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89(10):1016&#x2010;1023. doi:10.1136/jnnp-2017-317887</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;sus P, Fayemendy P, Nicol M, et al. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(1):97&#x2010;104. doi:10.1111/ene.13468</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13468</ArticleId><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med. 2007;9(1):17&#x2010;20. doi:10.1385/nmm:9:1:17</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/nmm:9:1:17</ArticleId><ArticleId IdType="pubmed">17114821</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53(5):1059&#x2010;1063. doi:10.1212/wnl.53.5.1059</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.53.5.1059</ArticleId><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, van Eijk RPA, Chachay V, et al. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7&#x2013;8):497&#x2010;505. doi:10.1080/21678421.2019.1621346</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1621346</ArticleId><ArticleId IdType="pubmed">31144522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezoian T, Belt E, Garry J, et al. Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia. Muscle Nerve. 2020;61(2):230&#x2010;234. doi:10.1002/mus.26749</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26749</ArticleId><ArticleId IdType="pubmed">31650547</ArticleId></ArticleIdList></Reference><Reference><Citation>Andermann ML, Lowell BB. Toward a wiring diagram understanding of appetite control. Neuron. 2017;95(4):757&#x2010;778. doi:10.1016/j.neuron.2017.06.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.06.014</ArticleId><ArticleId IdType="pmc">PMC5657399</ArticleId><ArticleId IdType="pubmed">28817798</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabery S, Ahmed RM, Caga J, Kiernan MC, Halliday GM, Peters&#xe9;n &#xc5;. Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2021;47:979&#x2010;989. doi:10.1111/nan.12709</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12709</ArticleId><ArticleId IdType="pubmed">33755993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M, Vercruysse P, M&#xfc;ller HP, et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88(12):1033&#x2010;1041. doi:10.1136/jnnp-2017-315795</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2010;299. doi:10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Ngo ST, Guo CC, et al. Patient with ALS with a novel TBK1 mutation, widespread brain involvement, behaviour changes and metabolic dysfunction. J Neurol Neurosurg Psychiatry. 2019;90(8):952&#x2010;954. doi:10.1136/jnnp-2018-318823</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318823</ArticleId><ArticleId IdType="pmc">PMC6691862</ArticleId><ArticleId IdType="pubmed">30196251</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE, a self bias&#x2010;field corrected sequence for improved segmentation and T1&#x2010;mapping at high field. Neuroimage. 2010;49(2):1271&#x2010;1281. doi:10.1016/j.neuroimage.2009.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2009.10.002</ArticleId><ArticleId IdType="pubmed">19819338</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien KR, Kober T, Hagmann P, et al. Robust T1&#x2010;weighted structural brain imaging and morphometry at 7T using MP2RAGE. PLoS One. 2014;9(6):e99676. doi:10.1371/journal.pone.0099676</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099676</ArticleId><ArticleId IdType="pmc">PMC4059664</ArticleId><ArticleId IdType="pubmed">24932514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Suh JW, Das SR, Pluta JB, Craige C, Yushkevich PA. Multi&#x2010;atlas segmentation with joint label fusion. IEEE Trans Pattern Anal Mach Intell. 2013;35(3):611&#x2010;623. doi:10.1109/tpami.2012.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/tpami.2012.143</ArticleId><ArticleId IdType="pmc">PMC3864549</ArticleId><ArticleId IdType="pubmed">22732662</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Steyn F, Ngo S, et al. Open&#x2010;Source Hypothalamic&#x2010;ForniX (OSHy&#x2010;X) Atlases and Segmentation Tool for 3T and 7T. J Open Source Soft. 2022;7(76):4368.</Citation></Reference><Reference><Citation>Chang J, Shaw TB. Open Source Hypothalamic&#x2010;ForniX (OSHy&#x2010;X) Atlases and Segmentation Tool for 3T and 7T; 2021. 10.17605/osf.io/zge9t. Accessed December 08, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.17605/osf.io/zge9t</ArticleId></ArticleIdList></Reference><Reference><Citation>Billot B, Bocchetta M, Todd E, Dalca AV, Rohrer JD, Iglesias JE. Automated segmentation of the hypothalamus and associated subunits in brain MRI. Neuroimage. 2020;223:117287. doi:10.1016/j.neuroimage.2020.117287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117287</ArticleId><ArticleId IdType="pmc">PMC8417769</ArticleId><ArticleId IdType="pubmed">32853816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry DW, Tomiyama AJ. Air displacement plethysmography versus dual&#x2010;energy x&#x2010;ray absorptiometry in underweight, normal&#x2010;weight, and overweight/obese individuals. PLoS One. 2015;10(1):e0115086. doi:10.1371/journal.pone.0115086</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115086</ArticleId><ArticleId IdType="pmc">PMC4301864</ArticleId><ArticleId IdType="pubmed">25607661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides Z, Steyn F, Mi J, Henderson R, McCombe P, Ngo S. Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass. Cogent Med. 2017;4(1):1343000.</Citation></Reference><Reference><Citation>Wilson MM, Thomas DR, Rubenstein LZ, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community&#x2010;dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074&#x2010;1081. doi:10.1093/ajcn/82.5.1074</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/82.5.1074</ArticleId><ArticleId IdType="pubmed">16280441</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1&#x2013;2):13&#x2010;21. doi:10.1016/s0022-510x(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>
R Core Team
. R: A Language and Environment for Statistical Computing. 2021. https://www.R&#x2010;project.org/
</Citation></Reference><Reference><Citation>Muth C, Oravecz Z, Gabry J. User&#x2010;friendly Bayesian regression modeling: a tutorial with rstanarm and shinystan. Quant Methods Psychol. 2018;14(2):99&#x2010;119.</Citation></Reference><Reference><Citation>Makowski D, Ben&#x2010;Shachar MS, Chen SHA, L&#xfc;decke D. Indices of effect existence and significance in the Bayesian framework. Front Psychol. 2019;10:2767. doi:10.3389/fpsyg.2019.02767</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2019.02767</ArticleId><ArticleId IdType="pmc">PMC6914840</ArticleId><ArticleId IdType="pubmed">31920819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides ZA, Steyn FJ, Henderson RD, McCombe PA, Ngo ST. Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(7&#x2013;8):486&#x2010;491. doi:10.1080/21678421.2017.1317811</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1317811</ArticleId><ArticleId IdType="pubmed">28446030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii M, Iadecola C. Metabolic and non&#x2010;cognitive manifestations of Alzheimer's disease: the hypothalamus as both culprit and target of pathology. Cell Metab. 2015;22(5):761&#x2010;776. doi:10.1016/j.cmet.2015.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.08.016</ArticleId><ArticleId IdType="pmc">PMC4654127</ArticleId><ArticleId IdType="pubmed">26365177</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet O, Peters&#xe9;n A, Yin Ka Lam B, et al. Eating and hypothalamus changes in behavioral&#x2010;variant frontotemporal dementia. Ann Neurol. 2011;69(2):312&#x2010;319. doi:10.1002/ana.22244</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22244</ArticleId><ArticleId IdType="pmc">PMC3084499</ArticleId><ArticleId IdType="pubmed">21387376</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M, Gordon E, Manning E, et al. Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia. J Neurol. 2015;262(12):2635&#x2010;2642. doi:10.1007/s00415-015-7885-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7885-2</ArticleId><ArticleId IdType="pmc">PMC4655011</ArticleId><ArticleId IdType="pubmed">26338813</ArticleId></ArticleIdList></Reference><Reference><Citation>White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46(10):1223&#x2010;1227. doi:10.1111/j.1532-5415.1998.tb04537.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.1998.tb04537.x</ArticleId><ArticleId IdType="pubmed">9777903</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Ren Q, Gong G, et al. Hypothalamic subregion abnormalities are related to body mass index in patients with sporadic amyotrophic lateral sclerosis. J Neurol. 2021;269:2980&#x2010;2988. doi:10.1007/s00415-021-10900-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10900-3</ArticleId><ArticleId IdType="pubmed">34779889</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137(5):715&#x2010;730. doi:10.1007/s00401-018-1933-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Jais A, Bruning JC. Hypothalamic inflammation in obesity and metabolic disease. J Clin Invest. 2017;127(1):24&#x2010;32. doi:10.1172/JCI88878</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI88878</ArticleId><ArticleId IdType="pmc">PMC5199695</ArticleId><ArticleId IdType="pubmed">28045396</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH Jr, Al&#x2010;Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(16):1602. doi:10.1056/NEJMc1710379</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1710379</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Irish M, Piguet O, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15(3):332&#x2010;342. doi:10.1016/s1474-4422(15)00380-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(15)00380-4</ArticleId><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kullmann S, Schweizer F, Veit R, Fritsche A, Preissl H. Compromised white matter integrity in obesity. Obes Rev. 2015;16(4):273&#x2010;281. doi:10.1111/obr.12248</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12248</ArticleId><ArticleId IdType="pubmed">25676886</ArticleId></ArticleIdList></Reference><Reference><Citation>Copenhaver BR, Rabin LA, Saykin AJ, et al. The fornix and mammillary bodies in older adults with Alzheimer's disease, mild cognitive impairment, and cognitive complaints: a volumetric MRI study. Psychiatry Res. 2006;147(2&#x2013;3):93&#x2010;103. doi:10.1016/j.pscychresns.2006.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pscychresns.2006.01.015</ArticleId><ArticleId IdType="pubmed">16920336</ArticleId></ArticleIdList></Reference><Reference><Citation>Makris N, Swaab DF, van der Kouwe A, et al. Volumetric parcellation methodology of the human hypothalamus in neuroimaging: normative data and sex differences. Neuroimage. 2013;69:1&#x2010;10. doi:10.1016/j.neuroimage.2012.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2012.12.008</ArticleId><ArticleId IdType="pmc">PMC3575213</ArticleId><ArticleId IdType="pubmed">23247186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman A, Hill J, Alvarez RM, Beck NL, Wu LL. Data Analysis Using Regression and Multilevel/Hierarchical Models. Cambridge University Press; 2006.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>